Zobrazeno 1 - 10
of 144
pro vyhledávání: '"J Lindtner"'
Autor:
A. Goldhirsch, Richard D. Gelber, S. Aebi, Edda Simoncini, Diana Crivellari, Barry A. Gusterson, Danielle Braun, Per Karlsson, Zhuoxin Sun, Meredith M. Regan, Manuela Rabaglio, Karen N. Price, J. Lindtner, M. Castiglione-Gertsch, Alan S. Coates, Raymond Snyder, Giuseppe Viale
Publikováno v:
Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754
Background: The benefit of adjuvant chemotherapy in postmenopausal patients with estrogen receptor (ER)-positive lymph node-negative breast cancer is being reassessed. Patients and methods: After stratification by ER status, 1669 postmenopausal patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf82f7af05b736383c5103e291b5c758
http://doc.rero.ch/record/304488/files/mdq754.pdf
http://doc.rero.ch/record/304488/files/mdq754.pdf
Autor:
Franco Cavalli, J. Lindtner, J. Collins, Diana Crivellari, Karen N. Price, O. Pagani, Alan S. Coates, Richard D. Gelber, Edda Simoncini, Aron Goldhirsch, Beat Thürlimann, Monica Castiglione, C. M. Rudenstam, Martin F. Fey, H.-J. Senn, A. O’Neill, John F. Forbes
Publikováno v:
Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; O'Neill, A.; Thürlimann, B.; Rudenstam, C.-M; Lindtner, J.; Collins, J.; Forbes, J.; Crivellari, D.; Coates, A.; Cavalli, F.; Simoncini, E.; Fey, M. F.; Pagani, O.; Price, K.; Senn, H.-J. (1997). Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology, 8(8), pp. 751-756. Oxford University Press 10.1023/A:1008220301866
Summary Purpose: It has been postulated that breast cancer surgery performed during the follicular phase of the menstrual cycle is associated with poorer outcome. Patients and methods: We tested this hypothesis by evaluating disease-free survival (DF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d57b6f343c353ccda86fd861a1940b
http://doc.rero.ch/record/290859/files/8-8-751.pdf
http://doc.rero.ch/record/290859/files/8-8-751.pdf
Autor:
Ph Morel, H. P. Do, W. Van den Bogaert, M. F. Fey, P. Hueber, H. Schefer, G. Goitein, S. Bressan, C. Verdan, W. Jeanneret Sozzi, L. Escudé, J. Heuberger, J. C. Horiot, O. Stadelmann, S. Balmer Majno, D. Schneiter, G. Lutters, A. Schott, Damien C. Weber, R. Mini, Peter Thum, Gábor J. Székely, G. Höpfl, B. Lippold, A. Coray, A. Azria, J. B. Davis, M. Betz, A. Hügli, Y. Zimmer, S. Berthou, Ch. Landmann, T. Boehringer, M. I. Saunders, S. Gourgou, L. Bortoluzzi, G. Ries, M. Allaoua, E. J. Born, A. Gallino, Christos Kolotas, G. Ueltschi, S. Bouville, Alessandra Bolsi, A. Richetti, K. T. Beer, S. Presilla, A. D. Roth, B. Streit, Richard H. Greiner, A. J. Lomax, F. Corminboeuf, J. Verwey, R. D. Gelber, J. Lindtner, O. Özsoy, R. Stupp, B. Thürlimann, R. H. Greiner, B. Hofstetter, I. F. Ciernik, M.-A. Bründler, C. von Briel, M. Honer, A. Merçay, E. Tschanz, M. Pruschy, L. Kemmerling, K. Rufibach, A. Franzetti, F. Luthi, A. Goldhirsch, J. Krayenbühl, St. Bodis, P. Martineau, Karl T. Beer, A. Pèlegrin, Peter D. Juelke, S. Cunat, J. Curschmann, M. Huser, A. Carbone, H. Rutz, Anthony Lomax, S. M. Bentzen, David Azria, W. Weder, N. Mach, H. Kranzbuehler, F. Mahler, L. Cozzi, P. Jichlinski, K. N. Price, M. Jörger, A. S. Coates, Christine Bouchardy, Frank Behrensmeier, Oscar Matzinger, Urs M. Lütolf, C. Taverna, H. Vees, D. Szczerba, R. Miralbell, D. Stalder, P. Pasche, C. Oehler, Eros Pedroni, M. Notter, P. Pujol, S. Bulling, W. Krek, D. Zingg, C. Larbouret, B. Pajic, G. Gruber, Oliver Riesterer, Beate Timmermann, L. Guillou, D. Weber, P. Dulguerov, P. Tebeu, F. Ludicke, P. Gervaz, Dagmar Laluhová, F. Munier, Abderrahim Zouhair, S. Lin, R. Gol-ouh, Ch. Taverna, M. Motta, R. Bigler, J. C. Luthi, S. Bieri, Malgorzata Roos, Paul Erne, S. Ganapathipillai, S. Ametamey, A. Tenzer, C. Burger, C. Bonny, B. J. Cummings, Stefanie Ohlerth, J. Bernier, M. Castiglione-Gertsch, M. Mollà, G. Pasche, J. F. Valley, G. Romieu, A. S. Allal, N. Stanek, U. Ulmer, Hans-Peter Hafner, S. Bodis, D. B. Evans, E. Pedroni, C.-M. Rudenstam, A. A. Khalil, G. Curti, D. M. Aebersold, C. Girardet, M. Jerman, A. Pica, G. Pache, E. Simoncini, R. Moeckli, T. Collen, A. Balmer, P. Mhawech, Peiman Jamshidi, Hans Peter Rutz, George N. Thalmann, Bernhard Isaak, E. E. Friedrich, M. Suleiman, M. Becker, D. Taussky, S. B. Holmberg, V. Vuong, Philippe Coucke, M. Abdou, Max Gassmann, G. Pesce, D. Crivellari, M. Weitzel, C. Rohrer Bley, H. Verkooijen, E. Schoenmaker, R. Stahel, R.O. Mirimanoff, C. Ares, M. Rouzaud, M. Bonetti, J. Collins, Barbara Kaser-Hotz, M. Bargetzi, P. Gertsch, H. P. Hafner, Y. Popowski, G. Nicolini, Natalie Inteeworn, Melanie Wergin, K. Allemann, P. Nouet, P. Kestenholz, H. Zenklusen, Brigitta G. Baumert, M. Usel, D. Lardinois, Therese Josephine Resink, S. Dische, H. Wang, H. Kranzbühler, T. Kebdani, D. Vetterli, H. J. Vees, W. Jochum, I. A. Norton, J. B. Dubois, C. Jargy, D. O. Slosman, A. Kramar, A. Fogliata, G. Studer, M. L. Nasi, Mahmut Ozsahin, G. Dipasquale, P. Huguenin
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3adcc2fa579d2d9f0fd5d3025a657d
https://pubmed.ncbi.nlm.nih.gov/27137923
https://pubmed.ncbi.nlm.nih.gov/27137923
Autor:
Nicole Rotmensz, Karen N. Price, Beat Thürlimann, John P. Collins, Diana Crivellari, C. Mendiola, O. Pagani, Edda Simoncini, Stefan Aebi, Aron Goldhirsch, Marco Colleoni, Richard D. Gelber, Alan S. Coates, Silvia Dellapasqua, M. Castiglione Gertsch, Aparna Keshaviah, J. Lindtner
Publikováno v:
Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492
BACKGROUND: We evaluated the ability of CA15-3 and alkaline phosphatase (ALP) to predict breast cancer recurrence. PATIENTS AND METHODS: Data from seven International Breast Cancer Study Group trials were combined. The primary end point was relapse-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c5d68c3cc0c56d8ed6caff6128c8ab
https://doi.org/10.1093/annonc/mdl492
https://doi.org/10.1093/annonc/mdl492
Autor:
Stig Holmberg, C.-M. Rudenstam, S. Li, Karen N. Price, Diana Crivellari, Andrea Veronesi, A. Goldhirsch, D. Eržen, John F. Forbes, Beat Thürlimann, Edda Simoncini, John P. Collins, Marco Colleoni, Olivia Pagani, M. Castiglione-Gertsch, R. D. Gelber, J. Lindtner, Elizabeth Murray, Alan S. Coates
Publikováno v:
Annals of Oncology. 16:716-725
Background Controversy persists about whether chemotherapy benefits all breast cancer patients. Patients and methods In the International Breast Cancer Study Group (IBCSG) trial VII, 1212 postmenopausal patients with node-positive disease were random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf13251463ab62a46af8d4360061590
https://doi.org/10.1093/annonc/mdi163
https://doi.org/10.1093/annonc/mdi163
Autor:
J. Lindtner, Stig Holmberg, I. Dudley Werner, C. Mendiola, Richard D. Gelber, Beat Thürlimann, M. Castiglione-Gertsch, John P. Collins, Diana Crivellari, Martin F. Fey, C.-M. Rudenstam, Alan S. Coates, Raymond Snyder, Aron Goldhirsch, S. Li, Edda Simoncini, D. Erien, Karen N. Price, Gilles Berclaz
Publikováno v:
Annals of Oncology. 15:875-884
Current information on the prognostic importance of body mass index (BMI) for patients with early breast cancer is based on a variety of equivocal reports. Few have data on BMI in relationship to systemic treatment.Patients (6792) were randomized to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c592719330de5c21c269ff2611d65d
https://doi.org/10.1093/annonc/mdh222
https://doi.org/10.1093/annonc/mdh222
Breast biopsy with wire localization: factors influencing complete excision of nonpalpable carcinoma
Publikováno v:
European Radiology. 12:2684-2689
Our aim was to find out the factors influencing the complete excision of nonpalpable carcinoma. During a 2-year period, 215 patients (median age 55 years) underwent biopsy after wire localization of 222 nonpalpable breast lesions. Mammographic, surgi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f89000e996d4372d9a1d6a9ee668d9
https://doi.org/10.1007/s00330-002-1331-4
https://doi.org/10.1007/s00330-002-1331-4
Autor:
Richard D. Gelber, J. Collins, Hernán Cortés-Funes, Diana Crivellari, M. Castiglione-Gertsch, J. Lindtner, S. Gelber, Stefan Aebi, I. D. Werner, Beat Thürlimann, A. Goldhirsch, C. M. Rudenstam, Edda Simoncini, Alan S. Coates
Publikováno v:
The Lancet. 355:1869-1874
The prognosis of breast cancer in very young women is generally considered to be unfavourable. Therefore, the outcome of adjuvant therapy was analysed in a population of young (35 years) premenopausal patients treated in four randomised controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dabe61f654cf0e3d6cbe60ec182c78df
https://doi.org/10.1016/s0140-6736(00)02292-3
https://doi.org/10.1016/s0140-6736(00)02292-3
Autor:
Alan S. Coates, Beat Thürlimann, Monica Castiglione-Gertsch, J Collins, A. Goldhirsch, C.-M. Rudenstam, R. D. Gelber, Karen N. Price, J. Lindtner, Marco Colleoni
Publikováno v:
European Journal of Cancer. 34:1693-1700
There is evidence in the literature of a relationship between dose and response to adjuvant chemotherapy for breast cancer, although published results are conflicting. We therefore retrospectively analysed the role of dose response in patients includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2861f3f844988707cd68b8746236cff8
https://doi.org/10.1016/s0959-8049(98)00209-3
https://doi.org/10.1016/s0959-8049(98)00209-3
Autor:
Mary Isley, H.-J. Senn, R. D. Gelber, J. Lindtner, Martin H.N. Tattersall, Anne Gudgeon, A Hacking, A. Goldhirsch, Monica Castiglione-Gertsch, C.-M. Rudenstam, J Collins, Alan S. Coates
Publikováno v:
European Journal of Cancer. 33:2321-2325
Breast cancer metastases appearing soon after adjuvant chemotherapy (within 12 months of its completion) are usually resistant to retreatment with the same cytotoxic agents, while relapses occurring later (beyond 12 months) regress when rechallenged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::212fb1fe8800eb63bfa2e14e1bbd2a09
https://doi.org/10.1016/s0959-8049(97)10011-9
https://doi.org/10.1016/s0959-8049(97)10011-9